Results 171 to 180 of about 29,397 (197)

ABCB1 Polymorphisms Influence on Temozolomide Resistance and Overall Survival in Glioblastoma Patients: A Systematic Review of Clinical Evidence. [PDF]

J Cell Mol Med
De Luca F, Mannino D, Capra AP, Ciappina G, Donato M, Caruso G, Esposito E, Ardizzone A.   +7 more
europepmc   +1 more source

Recurrent serotonin syndrome during low-dose venlafaxine treatment in a patient with reduced CYP2D6 activity. [PDF]

BMJ Case Rep
Bouti LNA, Graenicher A, Simona A, El Rida El Masri A, Samer CF.   +4 more
europepmc   +1 more source

Altered Membrane Protein Abundance in the Cerebral Cortex of the JNPL3 Mouse Model of Tauopathy. [PDF]

J Proteome Res
Petralla S, Hyvärinen J, Gynther M, Afonin A, Lehtonen M, Auriola S, Panayotova M, Kanninen KM, Fricker G, Puris E.   +9 more
europepmc   +1 more source

The Antidepressant Drug Clomipramine Inhibits the ABC Transporter BmrA. [PDF]

Chembiochem
Hellmann N, Kersten C, Efferth T, Schneider D.   +3 more
europepmc   +1 more source

Pharmacogenomics of direct oral anticoagulants: a systematic review and meta-analysis. [PDF]

Front Cardiovasc Med
Chai H, Huo J, Chen H.
europepmc   +1 more source

Investigating the Impact of ABCB1 3435C>T (rs1045642) Variant on Severity and Cognitive Decline in Egyptian Alzheimer's Disease Patients. [PDF]

Mol Neurobiol
Farouk YK, Nagy NE, El Amir AM, Madbouly NA, El-Khazragy N.   +4 more
europepmc   +1 more source

Ciprofloxacin Enhances the Chemosensitivity of Cancer Cells to ABCB1 Substrates

International Journal of Molecular Sciences, 2019
ABCB1 is one of the major drug efflux transporters that is known to cause multidrug resistance (MDR) in cancer patients receiving chemotherapy for the treatment of solid tumors and hematological malignancies.
Sabesan Yoganathan, Zhe-Sheng Chen, Pranav Gupta   +2 more
exaly   +2 more sources